Some visit links earn us a commission.
Quick verdict
Hims & Hers is the better pick for most patients on overall scoring. Same-day prescription, no lock-in and brand-name confidence. Hims pivoted to branded-only in March 2026 after settling with Novo Nordisk; compounded semaglutide is closed to new patients. Headline price is $299/mo branded Wegovy injectable (self-pay), plus $149/mo membership.
That said, Calibrate wins on specific dimensions. Calibrate is a coaching and insurance-navigation program whose value proposition has weakened as direct-to-consumer pricing from Lilly and Novo undercut the 'we'll handle insurance for you' pitch. Cut its fee from $299 to $199 in 2026.
Side-by-side
| Hims & Hers | Calibrate | |
|---|---|---|
| Starts from | $299/mo (incl. medication) | $224/mo (incl. medication) |
| Monthly cost gap | Calibrate is $75/mo cheaper than Hims & Hers | |
| Lock-in | Month-to-month | 3-mo minimum |
| Time to prescription | 1 day | 14 days |
| Consultation type | Asynchronous | Live |
| Affiliate network | Impact | Impact |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Hims & Hers | Calibrate | |
|---|---|---|
| Pricing transparency | 6/10 | 5/10 |
| Cancellation terms | 9/10 | 6/10 |
| Onboarding experience | 9/10 | 4/10 |
| Medication options | 5/10 | 7/10 |
| Member reviews | 6/10 | 9.2/10 |
When to choose Hims & Hers
Best for fast async onboarding
Patients who want a fast, low-friction async path to a branded GLP-1 prescription with predictable monthly pricing.
Hims & Hers wins on pricing transparency, cancellation terms, onboarding experience on the dimensional scoring. The caveat: Patients who wanted Hims's old compounded semaglutide tier or who need insurance-routed branded access. Compounded is closed to new patients. Note also: Settled with Novo Nordisk March 9, 2026 over compounded semaglutide marketing
When to choose Calibrate
Best for committed behavioral coaching
Patients who specifically want behavioral coaching and have insurance that covers branded GLP-1s. Calibrate's clinicians and coaches handle prior authorization paperwork well.
Calibrate wins on medication options, member reviews and runs $75/mo cheaper than Hims & Hers at the entry tier ($224 vs $299). Over a year that's $900 you keep. The caveat: Cash-pay patients. With $597 upfront plus $199/mo plus medication separate, the all-in is rarely under $400/mo. Direct LillyDirect or NovoCare paths beat this on price. Note also: Restructured in 2024 amid demand declines
If cost is your main filter
Calibrate is the cheaper monthly: $224 all-in vs $299 for Hims & Hers. That's $75 a month or $900a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $225 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Hims & Hers (month-to-month) and Calibrate (3-mo minimum) sit at different cancellation tiers. If you're first-time on a GLP-1 and unsure how you'll tolerate it, Hims & Hers's easier cancellation is the safer trial.
FAQ
Is Hims & Hers cheaper than Calibrate?
Can I switch from Hims & Hers to Calibrate mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
